Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $42.8100 (-4.14%) ($42.5100 - $42.8100) on Wed. Mar. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.44% (three month average) | RSI | 24 | Latest Price | $42.8100(-4.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1% a day on average for past five trading days. | Weekly Trend | TGTX declines -4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(64%) ARKK(59%) IBB(59%) IWO(59%) | Factors Impacting TGTX price | TGTX will decline at least -3.22% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-19%) UNG(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.22% (StdDev 6.44%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $33.03(-22.85%) | Inflection Point | Yes | Resistance Level | $46.93 | 5 Day Moving Average | $43.96(-2.62%) | 10 Day Moving Average | $44.74(-4.31%) | 20 Day Moving Average | $46.93(-8.78%) | To recent high | -21.8% | To recent low | 53.9% | Market Cap | $5.422b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |